BM
BioTech Medics, Inc.
BMCS · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $41.1K
P/E Ratio 6.57x
Div. Yield -
ROE 0.01%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap EV/EBITDA 3.56x
P/B 0.00x
P/E 6.57x
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
1 /100
Poor ROE 0.01%
ROA 0.01%
Asset turnover 0.00x
Debt
81 /100
Low Current ratio -0.00x
Net debt/EBITDA 0.19x
Debt/Equity 0.00x
Stability
1 /100
Unstable EPS volatility 174.93%
Profitable years 0
Beta 3.66x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BMCS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Anthony Keith Miller
Employees
0
Headquarters
Southlake